GeneVentiv Therapeutics Inc.
GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease.
Company Location
150 Fayetteville St., Suite 2300
Raleigh
NC
27601
County
Region
Company Details
Company type
Year founded
2020
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
GENV-HEM is a pre-IND gene therapy for hemophilia A and B with or without inhibitors. GENV-001 is a pre-clinical gene therapy for hemophilia arthropathy.